Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
REHOVOT, Israel, Dec. 5, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products, today announced a distribution agreement exclusive to independent retail with WinField United Canada for its bio-inoculant seed treatment Yalos™. This partnership aims to support Lavie Bio's 2024 sales growth strategy in Canada, with a focus on key agricultural regions, including Saskatchewan, Alberta, and Manitoba, where Yalos™ targets spring wheat, durum, and barley crops.
- The distribution agreement with WinField United Canada remains on point with Lavie Bio's strategy, further advancing the company's sales and distribution capability throughout Canada and the United States.
- Lavie Bio's intent is to engage with additional complimentary distribution partners to expand its sales reach throughout North America.
- Mr. Greg McDonald, President and General Manager of WinField United Canada, stated:
"WinField United Canada is excited to partner with Lavie Bio in an exclusive independent retailer distribution agreement on Yalos™. - Mr. Russel Putland, EVP Commercial & GM North America of Lavie Bio, stated: "I am very pleased with our WinField United Canada partnership.